Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-12-21
1995-05-02
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5482632, A61K 3141, C07D24912
Patent
active
054119804
ABSTRACT:
There are disclosed new substituted triazolinone, triazolinethione, and triazolinimine compounds which are useful as angiotensin II antagonists. These compounds have the general formula: ##STR1## wherein G is R.sup.1 or ##STR2##
REFERENCES:
patent: 5015651 (1991-05-01), Carini et al.
Burger, Medicinal Chemistry, 2d Edition (1960) pp. 565-571, 578-581 and 600-601.
Denkewalter et al., Progress in Drug Reserch 10, 510-512 (1966).
Ashton Wallace T.
Chakravarty Prasun K.
Chang Linda L.
Flanagan Kelly
Greenlee William J.
Camara Valerie J.
Daniel Mark R.
DiPrima Joseph F.
Merck & Co. , Inc.
Morris Patricia L.
LandOfFree
Substituted triazolinones, triazolinethiones, and triazolinimine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted triazolinones, triazolinethiones, and triazolinimine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted triazolinones, triazolinethiones, and triazolinimine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1137362